UPDATE: Needham & Company Starts Globus Medical (GMED) at Hold

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/4/2026

1. ZS
2. LULU
3. IOT
4. PATH
5. DOCU
6. SPY
7. ASAN
8. CIEN
9. GWRE
10. PL

September 26, 2017 4:14 PM EDT
Get Alerts GMED Hot Sheet
Price: $78.05 -0.09%

Rating Summary:
    22 Buy, 8 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
(Updated - September 26, 2017 4:16 PM EDT)

(updated with analyst comments)

Needham & Company initiates coverage on Globus Medical (NYSE: GMED) with a Hold rating.

Analyst Mike Matson is concerned that consensus 2018 estimates may be too high. In addition, they believe that GMED's earnings growth is going to be mostly driven by revenue growth.

Given this, and what they see as fair valuation, they initiate at Hold.

For an analyst ratings summary and ratings history on Globus Medical click here. For more ratings news on Globus Medical click here.

Shares of Globus Medical closed at $29.05 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, New Coverage

Related Entities

Needham & Company, Earnings